Safety and Efficacy Study of NUV-1511 in Adult Patients With Advanced Solid Tumors

Clinical Trials, Metastatic Castration Resistant Prostate Cancer (MCRPC)

— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives

NCT Number: NCT06334432
Phase: PHASE1|PHASE2
Trial Summary: NUV-1511-01 is a first-in human, open- label, Phase 1/2 to evaluate the safety and efficacy of NUV-1511 in patients with advanced solid tumors. The Phase 1 portion include patients with advanced solid – see clinicaltrials.gov for information and location
Clinicaltrials.gov
Trial Sponsor(s): Nuvation Bio Inc.
Acronym:

Pin It on Pinterest